146 related articles for article (PubMed ID: 15919919)
1. Analysis and function of prototype foamy virus envelope N glycosylation.
Lüftenegger D; Picard-Maureau M; Stanke N; Rethwilm A; Lindemann D
J Virol; 2005 Jun; 79(12):7664-72. PubMed ID: 15919919
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the prototype foamy virus envelope glycoprotein receptor-binding domain.
Duda A; Lüftenegger D; Pietschmann T; Lindemann D
J Virol; 2006 Aug; 80(16):8158-67. PubMed ID: 16873272
[TBL] [Abstract][Full Text] [Related]
3. Ubiquitination of the prototype foamy virus envelope glycoprotein leader peptide regulates subviral particle release.
Stanke N; Stange A; Lüftenegger D; Zentgraf H; Lindemann D
J Virol; 2005 Dec; 79(24):15074-83. PubMed ID: 16306578
[TBL] [Abstract][Full Text] [Related]
4. Prototype foamy virus envelope glycoprotein leader peptide processing is mediated by a furin-like cellular protease, but cleavage is not essential for viral infectivity.
Duda A; Stange A; Lüftenegger D; Stanke N; Westphal D; Pietschmann T; Eastman SW; Linial ML; Rethwilm A; Lindemann D
J Virol; 2004 Dec; 78(24):13865-70. PubMed ID: 15564494
[TBL] [Abstract][Full Text] [Related]
5. A particle-associated glycoprotein signal peptide essential for virus maturation and infectivity.
Lindemann D; Pietschmann T; Picard-Maureau M; Berg A; Heinkelein M; Thurow J; Knaus P; Zentgraf H; Rethwilm A
J Virol; 2001 Jul; 75(13):5762-71. PubMed ID: 11390578
[TBL] [Abstract][Full Text] [Related]
6. Mutations at the C-terminus of the simian immunodeficiency virus envelope glycoprotein affect gp120-gp41 stability on virions.
Affranchino JL; González SA
Virology; 2006 Mar; 347(1):217-25. PubMed ID: 16380144
[TBL] [Abstract][Full Text] [Related]
7. Mutations of conserved cysteine residues in the CWLC motif of the oncoretrovirus SU protein affect maturation and translocation.
Gu J; Parthasarathi S; Varela-Echavarría A; Ron Y; Dougherty JP
Virology; 1995 Feb; 206(2):885-93. PubMed ID: 7856101
[TBL] [Abstract][Full Text] [Related]
8. Correct capsid assembly mediated by a conserved YXXLGL motif in prototype foamy virus Gag is essential for infectivity and reverse transcription of the viral genome.
Mannigel I; Stange A; Zentgraf H; Lindemann D
J Virol; 2007 Apr; 81(7):3317-26. PubMed ID: 17229703
[TBL] [Abstract][Full Text] [Related]
9. N-terminal Gag domain required for foamy virus particle assembly and export.
Cartellieri M; Herchenröder O; Rudolph W; Heinkelein M; Lindemann D; Zentgraf H; Rethwilm A
J Virol; 2005 Oct; 79(19):12464-76. PubMed ID: 16160174
[TBL] [Abstract][Full Text] [Related]
10. A single glycosylation site within the receptor-binding domain of the avian sarcoma/leukosis virus glycoprotein is critical for receptor binding.
Delos SE; Burdick MJ; White JM
Virology; 2002 Mar; 294(2):354-63. PubMed ID: 12009877
[TBL] [Abstract][Full Text] [Related]
11. Identification of glycosylation sites in the SU component of the Avian Sarcoma/Leukosis virus Envelope Glycoprotein (Subgroup A) by mass spectrometry.
Kvaratskhelia M; Clark PK; Hess S; Melder DC; Federspiel MJ; Hughes SH
Virology; 2004 Aug; 326(1):171-81. PubMed ID: 15262505
[TBL] [Abstract][Full Text] [Related]
12. An evolutionarily conserved positively charged amino acid in the putative membrane-spanning domain of the foamy virus envelope protein controls fusion activity.
Pietschmann T; Zentgraf H; Rethwilm A; Lindemann D
J Virol; 2000 May; 74(10):4474-82. PubMed ID: 10775583
[TBL] [Abstract][Full Text] [Related]
13. Mutations within the transmembrane glycoprotein of Mason-Pfizer monkey virus: loss of SU-TM association and effects on infectivity.
Brody BA; Kimball MG; Hunter E
Virology; 1994 Aug; 202(2):673-83. PubMed ID: 8030233
[TBL] [Abstract][Full Text] [Related]
14. Influence of N-linked glycans on intracellular transport of hepatitis C virus E1 chimeric glycoprotein and its role in pseudotype virus infectivity.
Beyene A; Basu A; Meyer K; Ray R
Virology; 2004 Jul; 324(2):273-85. PubMed ID: 15207615
[TBL] [Abstract][Full Text] [Related]
15. Characterization of prototype foamy virus gag late assembly domain motifs and their role in particle egress and infectivity.
Stange A; Mannigel I; Peters K; Heinkelein M; Stanke N; Cartellieri M; Göttlinger H; Rethwilm A; Zentgraf H; Lindemann D
J Virol; 2005 May; 79(9):5466-76. PubMed ID: 15827161
[TBL] [Abstract][Full Text] [Related]
16. HCV E2 glycoprotein: mutagenesis of N-linked glycosylation sites and its effects on E2 expression and processing.
Slater-Handshy T; Droll DA; Fan X; Di Bisceglie AM; Chambers TJ
Virology; 2004 Feb; 319(1):36-48. PubMed ID: 14967486
[TBL] [Abstract][Full Text] [Related]
17. The envelope glycoproteins of dengue 1 and dengue 2 viruses grown in mosquito cells differ in their utilization of potential glycosylation sites.
Johnson AJ; Guirakhoo F; Roehrig JT
Virology; 1994 Sep; 203(2):241-9. PubMed ID: 8053148
[TBL] [Abstract][Full Text] [Related]
18. N-glycosylation at one rabies virus glycoprotein sequon influences N-glycan processing at a distant sequon on the same molecule.
Wojczyk BS; Takahashi N; Levy MT; Andrews DW; Abrams WR; Wunner WH; Spitalnik SL
Glycobiology; 2005 Jun; 15(6):655-66. PubMed ID: 15677380
[TBL] [Abstract][Full Text] [Related]
19. Processing, fusogenicity, virion incorporation and CXCR4-binding activity of a feline immunodeficiency virus envelope glycoprotein lacking the two conserved N-glycosylation sites at the C-terminus of the V3 domain.
González SA; Affranchino JL
Arch Virol; 2016 Jul; 161(7):1761-8. PubMed ID: 27020572
[TBL] [Abstract][Full Text] [Related]
20. Importance of the short cytoplasmic domain of the feline immunodeficiency virus transmembrane glycoprotein for fusion activity and envelope glycoprotein incorporation into virions.
Celma CC; Paladino MG; González SA; Affranchino JL
Virology; 2007 Sep; 366(2):405-14. PubMed ID: 17559903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
